Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × Magnetic Resonance Imaging × Clear all

Status

Unknown 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 15 Breast Neoplasms 9 Brain Neoplasms 6 Neoplasms 4 Urinary Bladder Neoplasms 3 Lymphoma, Non-Hodgkin 3 Spinal Cord Neoplasms 2 Multiple Myeloma 2 Lymphoma, B-Cell 2 Lymphoma 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocythemia, Essential 1 Thoracic Neoplasms 1 Thoracic Diseases 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Spinal Diseases 1 Solid Tumor, Adult 1 Sinusitis 1 Sarcoma 1 Retinoblastoma 1

Interventions

Doxorubicin 68 Ifosfamide 46 Filgrastim 36 Radiotherapy 33 Gemcitabine 31 Cyclophosphamide 29 Vincristine 21 Etoposide 21 Docetaxel 19 Cisplatin 19 pazopanib 18 Trabectedin 18 Carboplatin 15 Peripheral Blood Stem Cell Transplantation 12 pembrolizumab 11 Sorafenib 11 Mesna 11 Melphalan 11 Irinotecan 11 Sirolimus 10 Granulocyte Colony-Stimulating Factor 10 pegfilgrastim 9 eribulin 9 Topotecan 9 Paclitaxel 9 Bevacizumab 9 Temozolomide 8 Dactinomycin 8 Surgical Procedures, Operative 7 Methotrexate 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03658343 2025-02-21

T2* MRI Analysis for Sarcoma

University of Iowa

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡